Alembic Pharmaceuticals receive USFDA nod for Efinaconazole topical solution
Alembic Pharmaceuticals receive USFDA nod for Efinaconazole topical solution

Alembic Pharmaceuticals receive USFDA nod for Efinaconazole topical solution

Ganesh V Article rating: 5.0

Alembic Pharmaceuticals today announced that its joint venture, Aleor Dermaceuticals has received tentative approval from USFDA for its abbreviated new drug application (ANDA) for Efinaconazole topical solution, 10 per cent. 

Hester Biosciences gains 11 per cent post acquiring technology for production of 2 vaccines
Hester Biosciences gains 11 per cent post acquiring technology for production of 2 vaccines

Hester Biosciences gains 11 per cent post acquiring technology for production of 2 vaccines

Ganesh V Article rating: 3.5

Hester Biosciences Limited today announced that it has acquired technology from Indian Council of Agricultural Research-Indian Veterinary Research Institute (ICAR-IVRI) for the production and commercialisation of swine fever vaccine & sheep pox vaccine.

Minda Corporation surges 2 per cent on partnership with Ride Vision
Minda Corporation surges 2 per cent on partnership with Ride Vision

Minda Corporation surges 2 per cent on partnership with Ride Vision

Abhinav Lahoti Article rating: 3.7

Minda Corporation, which is a flagship company of Spark Minda, today announced its partnership with an Israel-based company named Ride Vision to bring its range of artificial intelligence-enabled collision avoidance technology (CAT) products in the Indian two-wheeler segment. 

Mahindra unveils brand name of its much-awaited SUV
Mahindra unveils brand name of its much-awaited SUV

Mahindra unveils brand name of its much-awaited SUV

Shruti Dahiwal Article rating: 3.7

Mahindra & Mahindra Ltd (M&M), a flagship company of Mahindra Group, announced this morning the brand name of its much-awaited SUV. The SUV, which is built on an all-new W601 platform will be named XUV700 (pronounced as XUV, 7 double ‘oh’).

Retirement planning with NPS
Retirement planning with NPS

Retirement planning with NPS

Henil Shah Article rating: 3.4

NPS is often viewed from a tax-saving point of view. Read onto know how to use it in your retirement planning.

Five stocks witnessing long Built-up
Five stocks witnessing long Built-up

Five stocks witnessing long Built-up

Ganesh Pawar Article rating: 4.1

The market opened in green on April 8, 2021, overall volumes in futures & options currently stand at 4,65,82,801 contracts with a turnover of Rs. 43,86,299.24 crore.

RSS
First19091910191119121914191619171918Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR